Regeneron Pharmaceuticals Could Trade Sideways Before Renewed Gains

Use available weakness to go long or add to longs.

CVS Health Reports and Here's How I'd Play It

CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.

On Quidel, Time to Book Profits and Take a Victory Lap

Technical analysis and trading strategy on the healthcare stock

CVS Must Be Taking Its Own Medicine: It's Looking Healthy

The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.

3 Promising Biotech Stocks to Buy on a Market Pullback

Eagle Pharmaceuticals, Biohaven Pharmaceuticals and Acadia Pharmaceuticals are names to consider on a 10% move down in equities.

Clorox Climbs and Could Clean Up Even More in the Months Ahead

Trading volume in the disinfectant maker's shares has been very active since February, which coincides with rising coronavirus fears.

We're All Rooting for Gilead Sciences in This Venture

I'm long GILD, but the fact is that the firm is not trying to make money off of Remdesivir at this point.

2 Picks, 2 Pans Among Small-Cap Biotechs Laboring in the Covid-19 Fields

Quotient Limited and Redhill Biopharma could deliver for shareholders, while Novavax Inc. and Inovio Pharmaceuticals may not in the end.

Wait for it: Centene Could Break Out to New Highs

Overall the charts of CNC are constructive but I would still want to buy strength.

Small-Caps Roar, Bets Against the Market, Trading Nvidia

Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.